Clinical Trials Directory

Trials / Completed

CompletedNCT02926716

NBI for Identifying Resection Margin Status in Gastric Cancer

Efficacy of Narrow Band Imaging Technique for Identifying Resection Margin Status After Gastrectomy for Gastric Cancer

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Ajou University School of Medicine · Academic / Other
Sex
All
Age
20 Years – 90 Years
Healthy volunteers
Not accepted

Summary

As the proportion of early gastric cancer has been steadily increased in Korea, so has function-preserving surgery. The function preserving surgery is characterized by the minimized extent of gastrectomy, so this implies that bilateral margins are getting shorter than those of standard gastrectomies. Currently, there is only one way to identify resection margin status in gastric cancer, 'frozen biopsy'. However, it is labor-intensive and time-consuming procedure. In addition, the results rely on the pathologist's expertise, thereby it showed limitation of its accuracy; high false negative rate of signet ring cell carcinoma was reported in a previous study. Recently, many studies on magnifying endoscopy with narrow band imaging(NBI) demonstrated that this emerging technique is useful to identify the gastric tumor margin more clearly in vivo, compared with conventional indigocarmine chromoendoscopy. So it was hypothesized that NBI may allow reliable delineation of tumor and identification of resection margin status in the specimen after gastrectomy for gastric cancer.

Detailed description

1. Tumor delineation and identification of resection margin: After specimen delivery from the abdomen, frozen biopsy is performed before checking tumor margin. After inspection with NBI, the tumor margin is marked with electrocauterization. The tumor size and the lengths of both resection margins are evaluated using a ruler. 2. Pathologic examination: The specimen is sliced as 4mm interval paralleled to the markings. Tumor size, the status of both resection margins, and microvessel density are evaluated under the 200 magnified view.

Conditions

Timeline

Start date
2015-12-14
Primary completion
2016-12-29
Completion
2016-12-29
First posted
2016-10-06
Last updated
2017-02-17

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02926716. Inclusion in this directory is not an endorsement.